Trevi Therapeutics to Participate in Upcoming June Conferences

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. PTC
2. NVDA
3. PCVX
4. META
5. MSFT
6. SPY
7. GOOGL
8. GMAB
9. USO
10. AMD

Go back to Trevi Therapeutics to Participate in Upcoming June Conferences

Trevi Therapeutics (TRVI) PT Raised to $23 at Oppenheimer

June 2, 2025 4:03 PM EDT

Oppenheimer analyst Leland Gershall raised the price target on Trevi Therapeutics (NASDAQ: TRVI) to $23.00 (from $20.00) while maintaining a Outperform rating.

The analyst comments "Further detail to this morning's positive topline Phase 2b announcement per the company's webcast with KOL and slides... More

Trevi Therapeutics (TRVI) Falls to LOD, Down ~7pct, Raymond James: 'This is a clean win and Haduvio has now set the bar in IPF-CC'

June 2, 2025 12:18 PM EDT

Raymond James analyst Ryan Deschner reiterated a Strong Buy rating and $29.00 price target on Trevi Therapeutics (NASDAQ: TRVI).

The analyst comments "Trevi reported statistically significant reductions on the 24-hr cough reduction primary endpoint in the Phase 2b CORAL study, including placebo-adjusted reductions >30% for all doses and a placebo-adjusted 43.3% reduction for the 108mg BID dose. This is a clean win and Haduvio has now... More